Drug resistance in recurrent cases of tuberculosis

Kekkaku

Volumn 79, Issue 8, 2004, Pages 461-467

  Ito, Kunihiko ^a   Wada, Masako ^a   Yoshiyama, Takashi ^a   Ohmori, Masako ^a   Ogata, Hideo ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b Japan Anti tuberculosis Association   (Japan)

Author keywords

Drop out; Drug resistance; Poor adherence; Recurrent tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; RECURRENT DISEASE; REVIEW; RISK FACTOR; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 4644313719     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Isseman MD: Tuberculosis chemotherapy, including Directly Observed Therapy. In: Clinician's Guide to Tuberculosis, Lippincott Williams & Wilkins, Philadelphia, 2000, 271-321.
2. Mitchison DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuber Lung Dis. 1998; 2: 10-15.